Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology

B Hallberg, RH Palmer - Nature Reviews Cancer, 2013 - nature.com
The burgeoning field of anaplastic lymphoma kinase (ALK) in cancer encompasses many
cancer types, from very rare cancers to the more prevalent non-small-cell lung cancer (NSCLC)…

[BOOK][B] The roots of rural poverty in Central and Southern Africa

RH Palmer, N Parsons - 1977 - books.google.com
… Robin Palmer and Neil Parsons Lusaka and Kwaluseni … What had given the white
farmers predominance by about 1930, as a number of the essays in this book demonstrate …

Anaplastic lymphoma kinase: signalling in development and disease

RH Palmer, E Vernersson, C Grabbe… - Biochemical …, 2009 - portlandpress.com
… This is in agreement with observations from the Palmer and Hallberg groups, who have also
generated ALK mutant mice (E. Vernersson, RH Palmer and B. Hallberg, unpublished work)…

Identification of in-hospital complications from claims data: is it valid?

…, EP McCarthy, RB Davis, LE Peterson, RH Palmer… - Medical care, 2000 - journals.lww.com
Objectives. This study examined the validity of the Complications Screening Program (CSP)
by testing whether (1) ICD-9-CM codes used to identify a complication are coded completely …

[HTML][HTML] The role of the ALK receptor in cancer biology

B Hallberg, RH Palmer - Annals of Oncology, 2016 - Elsevier
A vast array of oncogenic variants has been identified for anaplastic lymphoma kinase (ALK).
Therefore, there is a need to better understand the role of ALK in cancer biology in order to …

The efficacy and safety of milnacipran for treatment of fibromyalgia. a randomized, double-blind, placebo-controlled trial

…, SG Rao, J Kranzler, W Chen, RH Palmer - The Journal of …, 2009 - jrheum.org
Objective. To evaluate the safety and efficacy of milnacipran, a dual norepinephrine and
serotonin reuptake inhibitor, in the treatment of fibromyalgia (FM). Methods. A 27-week, …

Use of administrative data to find substandard care: validation of the complications screening program

SN Weingart, LI Iezzoni, RB Davis, RH Palmer… - Medical care, 2000 - journals.lww.com
Objective. The use of administrative data to identify inpatient complications is technically
feasible and inexpensive but unproven as a quality measure. Our objective was to validate …

Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial

DJ Clauw, P Mease, RH Palmer, RM Gendreau… - Clinical …, 2008 - Elsevier
… Gendreau, Palmer, and Clauw. The manuscript was prepared with the editorial assistance
of Prescott Medical Communications Group, Chicago, Illinois, under the supervision of Dr. …

Biological osteosynthesis

RH Palmer - Veterinary clinics: small animal practice, 1999 - vetsmall.theclinics.com
Palmer RH: Preoperative decision making in fracture management: The fracturepatient
assessment score (FPAS). In Proceedings of the Seventh Annual Complete Course in External …

Variation in office-based quality: a claims-based profile of care provided to Medicare patients with diabetes

…, DW Garnick, J Fowles, AG Lawthers, RH Palmer - Jama, 1995 - jamanetwork.com
Objectives. —To demonstrate that claims data "profiling" can be used as an on-going
method to support ambulatory care quality improvement; to measure the quality of office-based …